alector.com (ALEC) Company Long-Term Loans and Borrowings

Graphic logo of alector.com (ALEC)

Alector, Inc. (ALEC) develops unique antibodies for the therapy of Parkinson's and Alzheimer's pathologies, securing long-term market priority. The business relies on reprogramming brain immunity to halt neuronal aging. This chart illustrating the price evolution of the quotes shows long-term debt, which amounts to 0.00. Currently, Alector, Inc. (ALEC) is scaling its portfolio of high-relevance drugs while undergoing a stage of intensive clinical trials.

ALEC Alector Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for Alector (ALEC)

- price and consensus price forecast:
Stock Price Alector Inc.|ALEC - Price Target Chart
- market capitalization data:
Market Value Alector|ALEC - Total Company Value
- book capitalization data:
Net Asset Value per Share Alector|ALEC - Book Capitalization|Market Capitalization to Book Value Ratio alector.com|ALEC - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Alector, Inc.|ALEC - Long-Term Debt to Capital|Current Liabilities to Capital Alector Inc.|ALEC - Company Aggregate Debts|Debt to Book Value Alector|ALEC - Company Long-Term Liabilities|Amount of Current Liabilities Alector
Fundamental company valuation:ALEC - Alector, Inc.
Original product of alector.com

For Alector, Inc. (ALEC), which is developing innovative immuno-neurology without price controls, the organization's long-term financial debt reflects its capital raising strategy. This indicator captures the daily dynamics of liabilities with maturities exceeding one year, measuring the volume of external financing used for expansion. An increase in this metric signals a rising credit load and the risk of higher debt service costs should interest rates shift. This is a critical parameter for assessing the stability of biotechnological assets.

Competitors of Alector, Inc.

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACADIA Corp (ACAD) - Long-Term Debt|XENE (Xenon Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts VKTX|Company Long-Term Debt Supernus (SUPN)|Company Long-Term Debt Catalyst Pharma (CPRX)|DNLI: Company Long-Term Debts|Long-Term Debt Harmony Corp HRMY|BHVN: Company Long-Term Debts|amylyx.com (AMLX) - Company Long-Term Liabilities|TRVI - Company Long-Term Liabilities|PRAX (Praxis Precision Medicines Inc) - Amount of Long-Term Liabilities|Company Long-Term Debt AVXL (Anavex Corp)|Long-Term Debt CBLL|Prothena (PRTA) - Company Long-Term Debt|Company Long-Term Loans and Borrowings annexonbio.com ANNX|Company Long-Term Liabilities Omeros|Company Long-Term Loans and Borrowings Neurogene Inc NGNE|Company Long-Term Debts ACIU (AC Immune Corp)|VYGR: Long-Term Debt Volume|Company Long-Term Debt Neumora Therapeutics|scilexholding.com (SCLX) - Company Long-Term Indebtedness|Company Long-Term Debts TVGN|Company Long-Term Liabilities Alpha Cognition Corp (ACOG)|CGTX (Cognition Therapeutics) - Company Long-Term Liabilities|Long-Term Debt Volume Inhibikase Pharma (IKT)|Company Long-Term Debts SAVA (Cassava Sciences, Inc.)|Assertio Holdings - Company Long-Term Debts|COYA - Company Long-Term Debt|VTGN - Company Long-Term Debt|Company Long-Term Debts OVID|Acumen Pharmaceuticals, Inc (ABOS) - Long-Term Debt|Company Long-Term Debts CRVO|Company Long-Term Liabilities ATHE|Company Long-Term Debt Clene Inc. CLNN|Company Long-Term Indebtedness pepgen.com (PEPG)|JUNS: Company Long-Term Debts|RLMD - Long-Term Debt|Annovis Bio, Inc. - Company Long-Term Liabilities|GRCE: Company Long-Term Debts|Company Long-Term Debt Firefly Neuroscience AIFF|KLTO (Klotho Neurosciences) - Company Long-Term Loans and Borrowings|Company Long-Term Debt NRSN (NeuroSense Therapeutics Ltd)|Long-Term Debt Reviva Pharmaceuticals, Inc.|Company Long-Term Debts MTVA|Company Long-Term Debts NRXS (neuraxis.com)|Company Long-Term Debt Helius Medical Technologies HSDT|Company Long-Term Debt Passage Bio Inc. PASG|NEUP (Neuphoria) - Company Long-Term Debts|NERV - Long-Term Debt|ATHA (Athira Pharma, Inc.) - Company Long-Term Debts|Company Long-Term Liabilities addextherapeutics.com|Alzamend Neuro Inc. (ALZN) - Company Long-Term Liabilities|Amount of Long-Term Liabilities CYCN|Protagenic Therapeutics - Company Long-Term Debt|Long-Term Debt KTTA (pasitheaclinics.com)|Company Long-Term Debt Cortigent|ATXI - Company Long-Term Loans and Borrowings|Company Long-Term Liabilities BrainStorm Cell Therapeutics (BCLI)|CARA - Company Long-Term Loans and Borrowings|Chromocell Therapeutics Corporation - Company Long-Term Debts|ELYM (Eliem Therapeutics Inc.) - Long-Term Debt Volume|Company Long-Term Debt Intra-Cellular Therapies Inc. (ITCI)|Company Long-Term Indebtedness longboardpharma.com|Company Long-Term Debts MRNS (Marinus Pharmaceuticals, Inc.)|Company Long-Term Liabilities NKGen Biotech Inc NKGN|Company Long-Term Liabilities NRBO|Long-Term Debt Volume Sage Therapeutics Inc SAGE|Synaptogenix, Inc. - Company Long-Term Debts|TRVN: Company Long-Term Debts|vigilneuro.com (VIGL) - Company Long-Term Debt|Anew Medical Inc. (WENA) - Company Long-Term Debt|Company Long-Term Debts CERE (Cerevel)